TY  - JOUR
AU  - Astigarraga, Itziar
AU  - García-Obregón, Susana
AU  - Pérez-Martínez, Antonio
AU  - Gutiérrez-Carrasco, Ignacio
AU  - Santa-María, Vicente
AU  - Iturrate, Carmen Rodríguez-Vigil
AU  - Reggiori, Mikael Lorite
AU  - Carrillo, Thais Murciano
AU  - Torrent, Montse
AU  - Grupo de Histiocitosis de la Sociedad Española de Hematología y Oncología Pediátricas (SEHOP)
PY  - 2022
DO  - 10.1016/j.anpede.2022.05.005
UR  - http://hdl.handle.net/10668/21924
T2  - Anales de pediatria
AB  - Langerhans cell histiocytosis (LCH) is a type of myeloid neoplasia that can affect different organs or tissues and exhibits substantial variability in its clinical presentation and biological behaviour, so it may mimic different diseases. Performance...
LA  - en
KW  - BRAF inhibitors
KW  - Eosinophilic granuloma
KW  - Granuloma eosinófilo
KW  - Histiocitosis
KW  - Histiocitosis de células de langerhans
KW  - Histiocytic disorders
KW  - Histiocytosis
KW  - Inhibidores BRAF
KW  - Inhibidores MEK
KW  - Langerhans cell histiocytosis
KW  - MEK inhibitors
KW  - Medicina de precisión
KW  - Precision medicine
KW  - Síndromes histiocíticos
KW  - Targeted therapy
KW  - Terapia dirigida
KW  - Combined Modality Therapy
KW  - Histiocytosis, Langerhans-Cell
KW  - Humans
KW  - Mutation
KW  - Neoplasms
KW  - Prognosis
TI  - Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice.
TY  - research article
VL  - 97
ER  -